{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:24:20Z","timestamp":1793298260513,"version":"4.5.0"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024242","name":"SFI Research Centre for Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SFI 18\/EPSRC-CDT\/3587"],"award-info":[{"award-number":["SFI 18\/EPSRC-CDT\/3587"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejpb.2024.114517","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T19:33:26Z","timestamp":1727552006000},"page":"114517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Pharmacokinetic differences between subcutaneous injection and intradermal microneedle delivery of protein therapeutics"],"prefix":"10.1016","volume":"204","author":[{"given":"Laura","family":"Koenitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abina","family":"Crean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Vucen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5414\/CP203371","article-title":"Lines of therapy with biological drugs in dermatology, gastroenterology, and rheumatology practices in Germany","volume":"57","author":"Kostev","year":"2019","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/10717540802518082","article-title":"Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations","volume":"16","author":"So","year":"2009","journal-title":"Drug Deliv."},{"issue":"587","key":"10.1016\/j.ejpb.2024.114517_b0015","article-title":"Current trends in polymer microneedle for transdermal drug delivery","volume":"25","author":"Ahmed Saeed Al-Japairai","year":"2020","journal-title":"Int J Pharm."},{"issue":"11","key":"10.1016\/j.ejpb.2024.114517_b0020","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3390\/mi12111321","article-title":"Microneedles in drug delivery: progress and challenges","volume":"12","author":"Avcil","year":"2021","journal-title":"Micromachines"},{"key":"10.1016\/j.ejpb.2024.114517_b0025","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2022.05.045","article-title":"Dissolving microneedles: applications and growing therapeutic potential","volume":"348","author":"Sartawi","year":"2022","journal-title":"J. Control Release off. J. Control Release Soc."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114517_b0030","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/js980042+","article-title":"Microfabricated microneedles: a novel approach to transdermal drug delivery","volume":"87","author":"Henry","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2006.10.017","article-title":"Coated microneedles for transdermal delivery","volume":"117","author":"Gill","year":"2007","journal-title":"J Control Release off J Control Release Soc."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114517_b0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40005-021-00512-4","article-title":"Microneedle for transdermal drug delivery: current trends and fabrication","volume":"51","author":"Jung","year":"2021","journal-title":"J Pharm Investig."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0045","doi-asserted-by":"crossref","first-page":"2000307","DOI":"10.1002\/mabi.202000307","article-title":"Hydrogel-forming microneedles: current advancements and future trends","volume":"21","author":"Turner","year":"2021","journal-title":"Macromol Biosci."},{"issue":"267","key":"10.1016\/j.ejpb.2024.114517_b0050","article-title":"Trends of microneedle technology in the scientific literature, patents, clinical trials and internet activity","volume":"1","author":"Ingrole","year":"2021","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.ejpb.2024.114517_b0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2217\/pmt-2020-0041","article-title":"Development of a novel zolmitriptan intracutaneous microneedle system (QtryptaTM) for the acute treatment of migraine","volume":"10","author":"Rapoport","year":"2020","journal-title":"Pain Manag."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/17425255.2016.1149569","article-title":"Metabolic and redox barriers in the skin exposed to drugs and xenobiotics","volume":"12","author":"Korkina","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2011.01.039","article-title":"Incidence of low bioavailability of leuprolide acetate after percutaneous administration to rats by dissolving microneedles","volume":"407","author":"Ito","year":"2011","journal-title":"Int J Pharm."},{"key":"10.1016\/j.ejpb.2024.114517_b0070","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","article-title":"Microneedles: A smart approach and increasing potential for transdermal drug delivery system","volume":"109","author":"Waghule","year":"2019","journal-title":"Biomed Pharmacother Biomedecine Pharmacother."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0075","first-page":"461","article-title":"Subcutaneous administration of biotherapeutics: current experience in animal models","volume":"12","author":"McDonald","year":"2010","journal-title":"Curr Opin Mol Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40824-021-00226-6","article-title":"Recent advances in transdermal drug delivery systems: a review","volume":"25","author":"Jeong","year":"2021","journal-title":"Biomater Res."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clindermatol.2013.05.021","article-title":"Basic histological structure and functions of facial skin","volume":"32","author":"Arda","year":"2014","journal-title":"Clin Dermatol."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114517_b0090","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/jid.2012.246","article-title":"Structure and Function of the Stratum Corneum Extracellular Matrix","volume":"132","author":"Elias","year":"2012","journal-title":"J Invest Dermatol."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1523-1747.ep12598050","article-title":"The epidermal-dermal junction","volume":"65","author":"Briggaman","year":"1975","journal-title":"J Invest Dermatol."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jbiomech.2008.12.004","article-title":"The effect of composition and microstructure on the viscoelastic properties of dermis","volume":"42","author":"Ventre","year":"2009","journal-title":"J Biomech."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.15171\/apb.2018.021","article-title":"Chemical enhancer: a simplistic way to modulate barrier function of the Stratum Corneum","volume":"8","author":"Haque","year":"2018","journal-title":"Adv Pharm Bull."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114517_b0110","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1208\/s12248-012-9367-0","article-title":"mechanistic determinants of biotherapeutics absorption following SC Administration","volume":"14","author":"Richter","year":"2012","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114517_b0115","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.xphs.2018.01.007","article-title":"Challenges and opportunities for the subcutaneous delivery of therapeutic proteins","volume":"107","author":"Turner","year":"2018","journal-title":"J Pharm Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114517_b0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P","article-title":"Lymphatic transport of proteins after subcutaneous administration","volume":"89","author":"Porter","year":"2000","journal-title":"J Pharm Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-409X(01)00153-3","article-title":"Lymphatic transport of proteins after s.c. injection: implications of animal model selection","volume":"50","author":"Porter","year":"2001","journal-title":"Adv Drug Deliv Rev."},{"issue":"74","key":"10.1016\/j.ejpb.2024.114517_b0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2014.01.011","article-title":"Lymphatics in nanophysiology","volume":"30","author":"Hirakawa","year":"2014","journal-title":"Adv Drug Deliv Rev."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114517_b0135","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1084\/jem.20062596","article-title":"Functionally specialized junctions between endothelial cells of lymphatic vessels","volume":"204","author":"Baluk","year":"2007","journal-title":"J Exp Med."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(01)00150-8","article-title":"The physiology of the lymphatic system","volume":"50","author":"Swartz","year":"2001","journal-title":"Adv Drug Deliv Rev."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1087-0024.2000.00001.x","article-title":"Structure, function, and molecular control of the skin lymphatic system","volume":"5","author":"Skobe","year":"2000","journal-title":"J Investig Dermatol Symp Proc."},{"issue":"133","key":"10.1016\/j.ejpb.2024.114517_b0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yjmcc.2019.06.002","article-title":"Lymphatic system identification, pathophysiology and therapy in the cardiovascular diseases","volume":"1","author":"Hu","year":"2019","journal-title":"J Mol Cell Cardiol."},{"key":"10.1016\/j.ejpb.2024.114517_b0155","doi-asserted-by":"crossref","unstructured":"Ryan T j., Mortimer P s., Jones RL. Lymphatics of the Skin. Int J Dermatol. 1986;25(7):411\u20139.","DOI":"10.1111\/j.1365-4362.1986.tb03443.x"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ar.20765","article-title":"Anatomy of the subcutaneous lymph vascular network of the human leg in relation to the great saphenous vein","volume":"292","author":"Schacht","year":"2009","journal-title":"Anat Rec."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0165","first-page":"154","article-title":"Subcutaneous degradation of biosynthetic human growth hormone in growth hormone deficient patients","volume":"118","author":"J\u00f8rgensen","year":"1988","journal-title":"Acta Endocrinol (copenh)."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1248\/bpb1978.8.25","article-title":"Fate of porcine and human insulin at the subcutaneous injection site. I. Degradation and absorption of insulins in the rat","volume":"8","author":"Okumura","year":"1985","journal-title":"J Pharmacobiodyn."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.xphs.2019.08.005","article-title":"Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration","volume":"109","author":"Varkhede","year":"2020","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.ejpb.2024.114517_b0180","series-title":"Proteins and Peptides","article-title":"Metabolic Processes at Injection Sites Affecting Pharmacokinetics, Pharmacodynamics, and Metabolism of Protein and Peptide Therapeutics","author":"Mrsny","year":"2010"},{"issue":"10","key":"10.1016\/j.ejpb.2024.114517_b0185","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s11095-011-0451-4","article-title":"Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice","volume":"28","author":"van Beers","year":"2011","journal-title":"Pharm Res."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114517_b0190","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0041-008X(82)90149-1","article-title":"Methods for in vitro percutaneous absorption studies II. Animal models for human skin","volume":"62","author":"Bronaugh","year":"1982","journal-title":"Toxicol Appl Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114517_b0195","doi-asserted-by":"crossref","unstructured":"Jin J fen, Zhu L ling, Chen M, Xu H min, Wang H fen, Feng X qin, et al. The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection. Patient Prefer Adherence. 2015 Jul 2;9:923\u201342.","DOI":"10.2147\/PPA.S87271"},{"issue":"5","key":"10.1016\/j.ejpb.2024.114517_b0200","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/apt.15435","article-title":"Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease","volume":"50","author":"Truitt","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0205","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/dia.2010.0183","article-title":"Microneedle-Based Intradermal Versus Subcutaneous Administration of Regular Human Insulin or Insulin Lispro: Pharmacokinetics and Postprandial Glycemic Excursions in Patients with Type 1 Diabetes","volume":"13","author":"Pettis","year":"2011","journal-title":"Diabetes Technol Ther."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114517_b0210","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/pedi.12031","article-title":"Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes","volume":"14","author":"Norman","year":"2013","journal-title":"Pediatr Diabetes."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0215","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/dia.2010.0204","article-title":"Rapid Pharmacokinetics of Intradermal Insulin Administered Using Microneedles in Type 1 Diabetes Subjects","volume":"13","author":"Gupta","year":"2011","journal-title":"Diabetes Technol Ther."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0220","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/dia.2010.0184","article-title":"Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection","volume":"13","author":"Pettis","year":"2011","journal-title":"Diabetes Technol Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0225","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11095-010-0123-9","article-title":"Microneedle-Based Intradermal Delivery Enables Rapid Lymphatic Uptake and Distribution of Protein Drugs","volume":"28","author":"Harvey","year":"2011","journal-title":"Pharm Res."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0230","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/193229681200600403","article-title":"Pharmacokinetics and Postprandial Glycemic Excursions following Insulin Lispro Delivered by Intradermal Microneedle or Subcutaneous Infusion","volume":"6","author":"McVey","year":"2012","journal-title":"J Diabetes Sci Technol."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114517_b0235","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/dia.2016.0156","article-title":"Improved Insulin Pharmacokinetics Using a Novel Microneedle Device for Intradermal Delivery in Patients with Type 2 Diabetes","volume":"18","author":"Kochba","year":"2016","journal-title":"Diabetes Technol Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11095-010-0177-8","article-title":"Rapid intradermal delivery of liquid formulations using a hollow microstructured array","volume":"28","author":"Burton","year":"2011","journal-title":"Pharm Res."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114517_b0245","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1111\/bcp.14729","article-title":"Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial","volume":"87","author":"Jacobse","year":"2021","journal-title":"Br J Clin Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0250","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13075-017-1323-z","article-title":"Lymphatic delivery of etanercept via nanotopography improves response to collagen-induced arthritis","volume":"19","author":"Aldrich","year":"2017","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114517_b0255","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.xphs.2019.11.006","article-title":"Stabilization and Transdermal Delivery of an Investigational Peptide Using MicroCor\u00ae Solid-State Dissolving Microstructure Arrays","volume":"109","author":"Milewski","year":"2020","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.ejpb.2024.114517_b0260","doi-asserted-by":"crossref","unstructured":"Naito C, Katsumi H, Suzuki T, Quan Y shu, Kamiyama F, Sakane T, et al. Self-Dissolving Microneedle Arrays for Transdermal Absorption Enhancement of Human Parathyroid Hormone (1-34). Pharmaceutics. 2018 Dec;10(4):215.","DOI":"10.3390\/pharmaceutics10040215"},{"issue":"19","key":"10.1016\/j.ejpb.2024.114517_b0265","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.3390\/polym14194027","article-title":"Development of Clinical Weekly-Dose Teriparatide Acetate Encapsulated Dissolving Microneedle Patch for Efficient Treatment of Osteoporosis","volume":"14","author":"Sim","year":"2022","journal-title":"Polymers"},{"issue":"12","key":"10.1016\/j.ejpb.2024.114517_b0270","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1007\/s11095-014-1424-1","article-title":"Rapidly Dissolvable Microneedle Patches for Transdermal Delivery of Exenatide","volume":"31","author":"Zhu","year":"2014","journal-title":"Pharm Res."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0275","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s41598-018-19789-x","article-title":"Exendin-4-encapsulated dissolving microneedle arrays for efficient treatment of type 2 diabetes","volume":"8","author":"Fakhraei Lahiji","year":"2018","journal-title":"Sci Rep."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114517_b0280","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/dia.2009.0176","article-title":"Pharmacokinetic and Pharmacodynamic Evaluation of Insulin Dissolving Microneedles in Dogs","volume":"12","author":"Fukushima","year":"2010","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.ejpb.2024.114517_b0285","doi-asserted-by":"crossref","unstructured":"Liu S, Jin M na, Quan Y shu, Kamiyama F, Katsumi H, Sakane T, et al. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. J Controlled Release. 2012 Aug 10;161(3):933\u201341.","DOI":"10.1016\/j.jconrel.2012.05.030"},{"issue":"11","key":"10.1016\/j.ejpb.2024.114517_b0290","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1016\/j.actbio.2013.06.029","article-title":"Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats","volume":"9","author":"Ling","year":"2013","journal-title":"Acta Biomater."},{"issue":"24","key":"10.1016\/j.ejpb.2024.114517_b0295","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.actbio.2015.06.021","article-title":"Poly-\u03b3-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin","volume":"15","author":"Chen","year":"2015","journal-title":"Acta Biomater."},{"issue":"80","key":"10.1016\/j.ejpb.2024.114517_b0300","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.msec.2017.05.143","article-title":"Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin","volume":"1","author":"Yu","year":"2017","journal-title":"Mater Sci Eng c."},{"issue":"73","key":"10.1016\/j.ejpb.2024.114517_b0305","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.msec.2016.12.111","article-title":"Transdermal delivery of insulin with bioceramic composite microneedles fabricated by gelatin and hydroxyapatite","volume":"1","author":"Yu","year":"2017","journal-title":"Mater Sci Eng c."},{"issue":"71","key":"10.1016\/j.ejpb.2024.114517_b0310","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.msec.2016.10.063","article-title":"Fabrication of biodegradable composite microneedles based on calcium sulfate and gelatin for transdermal delivery of insulin","volume":"1","author":"Yu","year":"2017","journal-title":"Mater Sci Eng c."},{"issue":"85","key":"10.1016\/j.ejpb.2024.114517_b0315","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.msec.2017.12.006","article-title":"Microneedles fabricated from alginate and maltose for transdermal delivery of insulin on diabetic rats","volume":"1","author":"Zhang","year":"2018","journal-title":"Mater Sci Eng c."},{"issue":"232","key":"10.1016\/j.ejpb.2024.114517_b0320","article-title":"Implantable powder-carrying microneedles for transdermal delivery of high-dose insulin with enhanced activity","volume":"1","author":"Kim","year":"2020","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0325","doi-asserted-by":"crossref","first-page":"7914","DOI":"10.1038\/srep07914","article-title":"A patchless dissolving microneedle delivery system enabling rapid and efficient transdermal drug delivery","volume":"5","author":"Lahiji","year":"2015","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0330","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijpharm.2012.06.047","article-title":"Two-layered dissolving microneedles formulated with intermediate-acting insulin","volume":"436","author":"Ito","year":"2012","journal-title":"Int J Pharm."},{"issue":"612","key":"10.1016\/j.ejpb.2024.114517_b0335","article-title":"Microneedle patch-assisted transdermal administration of recombinant hirudin for the treatment of thrombotic diseases","volume":"25","author":"Men","year":"2022","journal-title":"Int J Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0340","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ajps.2022.02.005","article-title":"Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease","volume":"17","author":"Wu","year":"2022","journal-title":"Asian J Pharm Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114517_b0345","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/10611860801902575","article-title":"Percutaneous absorption of interferon-\u03b1 by self-dissolving micropiles","volume":"16","author":"Ito","year":"2008","journal-title":"J Drug Target."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0350","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/smll.201001091","article-title":"Dissolving microneedle patch for transdermal delivery of human growth hormone","volume":"7","author":"Lee","year":"2011","journal-title":"Small Weinh Bergstr Ger."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0355","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijpharm.2011.11.046","article-title":"Delivery of salmon calcitonin using a microneedle patch","volume":"423","author":"Tas","year":"2012","journal-title":"Int J Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0360","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10544-019-0462-1","article-title":"Coated microneedles for transdermal delivery of a potent pharmaceutical peptide","volume":"22","author":"Kapoor","year":"2019","journal-title":"Biomed Microdevices."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jc.2009-0358","article-title":"Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women","volume":"95","author":"Cosman","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.ejpb.2024.114517_b0370","doi-asserted-by":"crossref","unstructured":"Daddona PE, Matriano JamesA, Mandema J, Maa YF. Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis. Pharm Res. 2011 Jan 1;28(1):159\u201365.","DOI":"10.1007\/s11095-010-0192-9"},{"issue":"5","key":"10.1016\/j.ejpb.2024.114517_b0375","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s11095-022-03254-6","article-title":"The Relationship between the Drug Delivery Properties of a Formulation of Teriparatide Microneedles and the Pharmacokinetic Evaluation of Teriparatide Administration in Rats","volume":"39","author":"Oh","year":"2022","journal-title":"Pharm Res."},{"key":"10.1016\/j.ejpb.2024.114517_b0380","doi-asserted-by":"crossref","unstructured":"Liu S, Wu D, Quan Y shu, Kamiyama F, Kusamori K, Katsumi H, et al. Improvement of Transdermal Delivery of Exendin-4 Using Novel Tip-Loaded Microneedle Arrays Fabricated from Hyaluronic Acid. Mol Pharm. 2016 Jan 4;13(1):272\u20139.","DOI":"10.1021\/acs.molpharmaceut.5b00765"},{"issue":"102","key":"10.1016\/j.ejpb.2024.114517_b0385","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.msec.2019.04.063","article-title":"3D printed microneedle patches using stereolithography (SLA) for intradermal insulin delivery","volume":"1","author":"Economidou","year":"2019","journal-title":"Mater Sci Eng c."},{"issue":"40","key":"10.1016\/j.ejpb.2024.114517_b0390","doi-asserted-by":"crossref","first-page":"9335","DOI":"10.1039\/D0TB01822H","article-title":"Smart microneedle patches for rapid, and painless transdermal insulin delivery","volume":"8","author":"Wang","year":"2020","journal-title":"J Mater Chem b."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0395","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/8\/1\/015006","article-title":"Development of a drug-coated microneedle array and its application for transdermal delivery of interferon alpha","volume":"8","author":"Kusamori","year":"2016","journal-title":"Biofabrication"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0400","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/pharmaceutics6020220","article-title":"Human Growth Hormone Delivery with a Microneedle Transdermal System: Preclinical Formulation, Stability, Delivery and PK of Therapeutically Relevant Doses","volume":"6","author":"Ameri","year":"2014","journal-title":"Pharmaceutics."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114517_b0405","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s11095-012-0674-z","article-title":"Erythropoietin-Coated ZP-Microneedle Transdermal System: Preclinical Formulation, Stability, and Delivery","volume":"29","author":"Peters","year":"2012","journal-title":"Pharm Res."},{"issue":"29","key":"10.1016\/j.ejpb.2024.114517_b0410","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1002\/adfm.201500554","article-title":"Phase-Transition Microneedle Patches for Efficient and Accurate Transdermal Delivery of Insulin","volume":"25","author":"Yang","year":"2015","journal-title":"Adv Funct Mater."},{"issue":"89","key":"10.1016\/j.ejpb.2024.114517_b0415","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejpb.2014.11.013","article-title":"Analysis of the absorption kinetics of macromolecules following intradermal and subcutaneous administration","volume":"1","author":"Milewski","year":"2015","journal-title":"Eur J Pharm Biopharm."},{"issue":"315","key":"10.1016\/j.ejpb.2024.114517_b0420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2019.10.040","article-title":"Removal of interstitial hyaluronan with recombinant human hyaluronidase improves the systemic and lymphatic uptake of cetuximab in rats","volume":"10","author":"Styles","year":"2019","journal-title":"J Controlled Release."},{"issue":"599","key":"10.1016\/j.ejpb.2024.114517_b0425","article-title":"Hollow microneedles: A perspective in biomedical applications","volume":"15","author":"C\u00e1rcamo-Mart\u00ednez","year":"2021","journal-title":"Int J Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0430","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1208\/s12249-019-1560-3","article-title":"Transdermal Microneedles\u2014A Materials Perspective","volume":"21","author":"Ali","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2024.114517_b0435","doi-asserted-by":"crossref","DOI":"10.3390\/bioengineering5030059","article-title":"Three-Dimensional (3D) Printed Microneedles for Microencapsulated Cell Extrusion","author":"Farias","year":"2018","journal-title":"Bioengineering [internet]."},{"issue":"605","key":"10.1016\/j.ejpb.2024.114517_b0440","article-title":"3D printed hollow microneedles array using stereolithography for efficient transdermal delivery of rifampicin","volume":"10","author":"Yadav","year":"2021","journal-title":"Int J Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0445","doi-asserted-by":"crossref","first-page":"e716","DOI":"10.1210\/clinem\/dgab709","article-title":"Extended Injection Intervals of Gonadotropins by Intradermal Administration in IVF Treatment","volume":"107","author":"Hsu","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.ejpb.2024.114517_b0450","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejpb.2022.02.013","article-title":"Trends in drug- and vaccine-based dissolvable microneedle materials and methods of fabrication","volume":"173","author":"Moore","year":"2022","journal-title":"Eur J Pharm Biopharm off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV."},{"issue":"103","key":"10.1016\/j.ejpb.2024.114517_b0455","article-title":"Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies","volume":"1","author":"Sharma","year":"2019","journal-title":"Mater Sci Eng c."},{"issue":"218","key":"10.1016\/j.ejpb.2024.114517_b0460","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2015.10.002","article-title":"IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery","volume":"28","author":"M\u00f6nk\u00e4re","year":"2015","journal-title":"J Controlled Release."},{"issue":"19","key":"10.1016\/j.ejpb.2024.114517_b0465","doi-asserted-by":"crossref","first-page":"1700326","DOI":"10.1002\/adhm.201700326","article-title":"Centrifugal Lithography: Self-Shaping of Polymer Microstructures Encapsulating Biopharmaceutics by Centrifuging Polymer Drops","volume":"6","author":"Yang","year":"2017","journal-title":"Adv Healthc Mater."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0470","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/adma.200902418","article-title":"Drawing Lithography: Three-Dimensional Fabrication of an Ultrahigh-Aspect-Ratio Microneedle","volume":"22","author":"Lee","year":"2010","journal-title":"Adv Mater."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114517_b0475","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jconrel.2013.05.026","article-title":"Droplet-born air blowing: Novel dissolving microneedle fabrication","volume":"170","author":"Kim","year":"2013","journal-title":"J Controlled Release."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114517_b0480","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s11095-006-0028-9","article-title":"Polymer Microneedles for Controlled-Release Drug Delivery","volume":"23","author":"Park","year":"2006","journal-title":"Pharm Res."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0485","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.3390\/polym11020369","article-title":"Spray-Formed Layered Polymer Microneedles for Controlled Biphasic Drug Delivery","volume":"11","author":"Park","year":"2019","journal-title":"Polymers"},{"issue":"145","key":"10.1016\/j.ejpb.2024.114517_b0490","article-title":"Shape of dissolving microneedles determines skin penetration ability and efficacy of drug delivery","volume":"1","author":"Min","year":"2023","journal-title":"Biomater Adv."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0495","doi-asserted-by":"crossref","first-page":"2226367","DOI":"10.1080\/10717544.2023.2226367","article-title":"Triptorelin nanoparticle-loaded microneedles for use in assisted reproductive technology","volume":"30","author":"Lu","year":"2023","journal-title":"Drug Deliv."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114517_b0500","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1007\/s13346-021-01056-8","article-title":"Advances in microneedle-based transdermal delivery for drugs and peptides","volume":"12","author":"Aich","year":"2022","journal-title":"Drug Deliv Transl Res."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114517_b0505","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.119.258707","article-title":"Microneedle Coating Methods: A Review with a Perspective","volume":"370","author":"Ingrole","year":"2019","journal-title":"J Pharmacol Exp Ther."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114517_b0510","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1007\/s13346-017-0466-4","article-title":"An update on coating\/manufacturing techniques of microneedles","volume":"8","author":"Tarbox","year":"2018","journal-title":"Drug Deliv Transl Res."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114517_b0515","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1039\/C7LC00016B","article-title":"Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing","volume":"17","author":"Wang","year":"2017","journal-title":"Lab Chip."},{"issue":"38","key":"10.1016\/j.ejpb.2024.114517_b0520","first-page":"95","article-title":"Hydrogel forming microneedles loaded with VEGF and Ritlecitinib\/polyhydroxyalkanoates nanoparticles for mini-invasive androgenetic alopecia treatment","volume":"1","author":"Ding","year":"2024","journal-title":"Bioact Mater."},{"issue":"151","key":"10.1016\/j.ejpb.2024.114517_b0525","article-title":"Antimicrobial releasing hydrogel forming microneedles","volume":"1","author":"Turner","year":"2023","journal-title":"Biomater Adv."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114517_b0530","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1021\/acs.molpharmaceut.8b00544","article-title":"Microneedle-Mediated Transdermal Delivery of Bevacizumab","volume":"15","author":"Courtenay","year":"2018","journal-title":"Mol Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0535","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11095-011-0578-3","article-title":"Subcutaneous Absorption of Monoclonal Antibodies: Role of Dose, Site of Injection, and Injection Volume on Rituximab Pharmacokinetics in Rats","volume":"29","author":"Kagan","year":"2012","journal-title":"Pharm Res."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114517_b0540","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1124\/dmd.107.015669","article-title":"Lymphatic absorption of subcutaneously administered proteins: influence of different injection sites on the absorption of darbepoetin alfa using a sheep model","volume":"35","author":"Kota","year":"2007","journal-title":"Drug Metab Dispos."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0545","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diacare.5.2.77","article-title":"Absorption kinetics and biologic effects of subcutaneously injected insulin preparations","volume":"5","author":"Berger","year":"1982","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0550","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clinthera.2005.02.008","article-title":"A randomized, open-label, crossover study examiningthe effect of injection site on bioavailability of exenatide (synthetic exendin-4)","volume":"27","author":"Calara","year":"2005","journal-title":"Clin Ther."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114517_b0555","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0091270009340782","article-title":"Subcutaneous Bioavailability of Golimumab at 3 Different Injection Sites in Healthy Subjects","volume":"50","author":"Xu","year":"2010","journal-title":"J Clin Pharmacol."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114517_b0560","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1185\/03007995.2010.481203","article-title":"Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations","volume":"26","author":"Gibney","year":"2010","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.ejpb.2024.114517_b0565","doi-asserted-by":"crossref","unstructured":"Swartz MA, BOARDMAN Jr. KC. The Role of Interstitial Stress in Lymphatic Function and Lymphangiogenesis. Ann N Y Acad Sci. 2002;979(1):197\u2013210.","DOI":"10.1111\/j.1749-6632.2002.tb04880.x"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0570","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-199733040-00004","article-title":"Pharmacokinetic Considerations of New Insulin Formulations and Routes of Administration","volume":"33","author":"Hoffman","year":"1997","journal-title":"Clin Pharmacokinet."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0575","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejps.2008.10.018","article-title":"Absorption kinetics of insulin after subcutaneous administration","volume":"36","author":"S\u00f8eborg","year":"2009","journal-title":"Eur J Pharm Sci."},{"issue":"153","key":"10.1016\/j.ejpb.2024.114517_b0580","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.addr.2019.10.004","article-title":"Intradermal and transdermal drug delivery using microneedles \u2013 Fabrication, performance evaluation and application to lymphatic delivery","volume":"1","author":"Sabri","year":"2020","journal-title":"Adv Drug Deliv Rev."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0585","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/antib8040056","article-title":"Understanding Inter-Individual Variability in Monoclonal Antibody Disposition","volume":"8","author":"Thomas","year":"2019","journal-title":"Antibodies"},{"issue":"11","key":"10.1016\/j.ejpb.2024.114517_b0590","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1007\/s13346-022-01123-8","article-title":"A novel method for fabrication of coated microneedles with homogeneous and controllable drug dosage for transdermal drug delivery","volume":"12","author":"Chen","year":"2022","journal-title":"Drug Deliv Transl Res."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114517_b0595","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1248\/cpb.56.243","article-title":"Antihyperglycemic Effect of Insulin from Self-Dissolving Micropiles in Dogs","volume":"56","author":"Ito","year":"2008","journal-title":"Chem Pharm Bull (tokyo)."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0600","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10856-009-3923-x","article-title":"Self-dissolving micropile array tips for percutaneous administration of insulin","volume":"21","author":"Ito","year":"2010","journal-title":"J Mater Sci Mater Med."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0605","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1021\/acsbiomaterials.0c00120","article-title":"Fabrication of Tip-Hollow and Tip-Dissolvable Microneedle Arrays for Transdermal Drug Delivery","volume":"6","author":"Ye","year":"2020","journal-title":"ACS Biomater Sci Eng."},{"key":"10.1016\/j.ejpb.2024.114517_b0610","article-title":"Dissolving Polymer Microneedles for Transdermal Delivery of Insulin","author":"Zhang","year":"2021","journal-title":"Front Pharmacol [internet]."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114517_b0615","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s11095-011-0419-4","article-title":"Laser-Engineered Dissolving Microneedle Arrays for Transdermal Macromolecular Drug Delivery","volume":"28","author":"Migalska","year":"2011","journal-title":"Pharm Res."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0620","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13346-021-01048-8","article-title":"Dissolving microneedle rollers for rapid transdermal drug delivery","volume":"12","author":"Zhang","year":"2022","journal-title":"Drug Deliv Transl Res."},{"issue":"644","key":"10.1016\/j.ejpb.2024.114517_b0625","article-title":"Practicality of non-invasive glucagon-loaded dissolving microneedle for life-saving treatment of severe hypoglycemia in a diabetic rat model","volume":"25","author":"Wang","year":"2023","journal-title":"Int J Pharm."},{"issue":"171","key":"10.1016\/j.ejpb.2024.114517_b0630","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.actbio.2023.09.010","article-title":"Functional insulin aspart\/insulin degludec-based microneedles for promoting postprandial glycemic control","volume":"1","author":"Chen","year":"2023","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01865-z","article-title":"Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics","volume":"22","author":"Zhang","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.ejpb.2024.114517_b0640","doi-asserted-by":"crossref","first-page":"E235","DOI":"10.3390\/pharmaceutics11050235","article-title":"Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment","volume":"11","author":"Cao","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2024.114517_b0645","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac041","article-title":"Delivering an mRNA vaccine using a lymphatic drug delivery device improves humoral and cellular immunity against SARS-CoV-2","author":"Chen","year":"2022","journal-title":"J Mol Cell Biol."},{"issue":"26","key":"10.1016\/j.ejpb.2024.114517_b0650","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.7150\/thno.35280","article-title":"Nanotopography-based lymphatic delivery for improved anti-tumor responses to checkpoint blockade immunotherapy","volume":"9","author":"Kwon","year":"2019","journal-title":"Theranostics."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114517_b0655","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3390\/cancers14071823","article-title":"Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy","volume":"14","author":"Mantilla-Rojas","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114517_b0660","doi-asserted-by":"crossref","first-page":"e1690","DOI":"10.1002\/wnan.1690","article-title":"Recent advances in combination of microneedles and nanomedicines for lymphatic targeted drug delivery","volume":"13","author":"Permana","year":"2021","journal-title":"Wires Nanomedicine Nanobiotechnology."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114517_b0665","doi-asserted-by":"crossref","first-page":"e231430","DOI":"10.1001\/jamahealthforum.2023.1430","article-title":"Estimated Changes in Insulin Prices and Discounts After Entry of New Insulin Products, 2012\u20132019","volume":"4","author":"Dickson","year":"2023","journal-title":"JAMA Health Forum."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114517_b0670","first-page":"e10358","article-title":"Erythropoietin Administration for Anemia Due to Chronic Kidney Disease - Subcutaneous OR Intravenous, What Do We Know So Far","volume":"12","author":"Shahab","year":"2020","journal-title":"Cureus."},{"key":"10.1016\/j.ejpb.2024.114517_b0675","doi-asserted-by":"crossref","unstructured":"Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle-Based Vaccines. In: Compans RW, Orenstein WA, editors. Vaccines for Pandemic Influenza [Internet]. Berlin, Heidelberg: Springer; 2009 [cited 2024 Jan 26]. p. 369\u201393. (Current Topics in Microbiology and Immunology). Available from: https:\/\/doi.org\/10.1007\/978-3-540-92165-3_18.","DOI":"10.1007\/978-3-540-92165-3_18"},{"issue":"41","key":"10.1016\/j.ejpb.2024.114517_b0680","article-title":"Comparison of equivalent fractional vaccine doses delivered by intradermal and intramuscular or subcutaneous routes: A systematic review","volume":"1","author":"Schnyder","year":"2021","journal-title":"Travel Med Infect Dis."},{"issue":"11","key":"10.1016\/j.ejpb.2024.114517_b0685","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.3390\/v14112438","article-title":"Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis","volume":"14","author":"Quach","year":"2022","journal-title":"Viruses"},{"issue":"48","key":"10.1016\/j.ejpb.2024.114517_b0690","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1016\/j.vaccine.2015.10.088","article-title":"Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A randomized controlled phase III study","volume":"33","author":"Arakane","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ejpb.2024.114517_b0695","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1021\/acsabm.9b00730","article-title":"A Dissolvable Microneedle Formulation of Bordetella pertussis Subunit Vaccine: Translational Development and Immunological Evaluation in Mice","volume":"2","author":"Zhu","year":"2019","journal-title":"ACS Appl Bio Mater."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114517_b0700","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/toxins14120881","article-title":"A thermostable dissolving microneedle vaccine with recombinant protein of botulinum neurotoxin Serotype A","volume":"14","author":"Zhao","year":"2022","journal-title":"Toxins."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114517_b0705","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jconrel.2012.07.039","article-title":"Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations","volume":"162","author":"Pattani","year":"2012","journal-title":"J Controlled Release."},{"issue":"34","key":"10.1016\/j.ejpb.2024.114517_b0710","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1016\/j.vaccine.2012.09.062","article-title":"Measles vaccination using a microneedle patch","volume":"31","author":"Edens","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2024.114517_b0715","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01789","article-title":"Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid","author":"de Groot","year":"2017","journal-title":"Front Immunol [internet]."},{"issue":"17","key":"10.1016\/j.ejpb.2024.114517_b0720","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.3390\/ijms241713587","article-title":"Immune Response of Inactivated Rabies Vaccine Inoculated via Intraperitoneal, Intramuscular, Subcutaneous and Needle-Free Injection Technology-Based Intradermal Routes in Mice","volume":"24","author":"Zhao","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0725","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jdermsci.2022.04.001","article-title":"Immunogenicity of varicella-zoster virus vaccine by different routes of administration: Comparable vaccination efficacy of one-fifth dose intradermal vaccination to conventional subcutaneous vaccination","volume":"106","author":"Nakamura-Nishimura","year":"2022","journal-title":"J Dermatol Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114517_b0730","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1473-3099(16)00133-X","article-title":"Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial","volume":"16","author":"Beals","year":"2016","journal-title":"Lancet Infect Dis."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114517_b0735","doi-asserted-by":"crossref","first-page":"2300253","DOI":"10.1002\/mabi.202300253","article-title":"A Rapidly Dissolvable Microneedle Patch with Tip-Accumulated Antigens for Efficient Transdermal Vaccination","volume":"23","author":"Zheng","year":"2023","journal-title":"Macromol Biosci."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114517_b0740","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/adhm.201300312","article-title":"Nanocomposite-Strengthened Dissolving Microneedles for Improved Transdermal Delivery to Human Skin","volume":"3","author":"Yan","year":"2014","journal-title":"Adv Healthc Mater."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114517_b0745","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejpb.2014.05.003","article-title":"Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice","volume":"88","author":"van der Maaden","year":"2014","journal-title":"Eur J Pharm Biopharm."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114517_b0750","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1208\/s12249-017-0730-4","article-title":"Enhancement of Skin Permeation and Skin Immunization of Ovalbumin Antigen via Microneedles","volume":"18","author":"Pamornpathomkul","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"39","key":"10.1016\/j.ejpb.2024.114517_b0755","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102595118","article-title":"Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity","volume":"118","author":"Caudill","year":"2021","journal-title":"Proc Natl Acad Sci U S a."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114517_b0760","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2147\/IJN.S125945","article-title":"A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin","volume":"27","author":"Pamornpathomkul","year":"2017","journal-title":"Int J Nanomedicine."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0765","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1208\/s12249-017-0855-5","article-title":"Cationic Niosomes for Enhanced Skin Immunization of Plasmid DNA-Encoding Ovalbumin via Hollow Microneedles","volume":"19","author":"Pamornpathomkul","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"16","key":"10.1016\/j.ejpb.2024.114517_b0770","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/smll.201000331","article-title":"Nanopatch-targeted skin vaccination against west nile virus and chikungunya virus in mice","volume":"6","author":"Prow","year":"2010","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0775","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.1038\/s41598-018-30290-3","article-title":"Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch)","volume":"8","author":"Koh","year":"2018","journal-title":"Sci Rep."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114517_b0780","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1007\/s13346-023-01298-8","article-title":"Sustained antigens delivery using composite microneedles for effective epicutaneous immunotherapy","volume":"13","author":"Zhang","year":"2023","journal-title":"Drug Deliv Transl Res."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114517_b0785","doi-asserted-by":"crossref","first-page":"10272","DOI":"10.1021\/acsnano.8b05373","article-title":"Synthetic charge-invertible polymer for rapid and complete implantation of layer-by-layer microneedle drug films for enhanced transdermal vaccination","volume":"12","author":"He","year":"2018","journal-title":"ACS Nano"},{"issue":"268","key":"10.1016\/j.ejpb.2024.114517_b0790","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2017.10.021","article-title":"Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management of acute migraine therapy","volume":"28","author":"Tas","year":"2017","journal-title":"J Controlled Release."},{"issue":"566","key":"10.1016\/j.ejpb.2024.114517_b0795","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijpharm.2019.05.066","article-title":"Rapidly dissolving bilayer microneedle arrays \u2013 A minimally invasive transdermal drug delivery system for vitamin B12","volume":"20","author":"Ram\u00f6ller","year":"2019","journal-title":"Int J Pharm."},{"issue":"628","key":"10.1016\/j.ejpb.2024.114517_b0800","article-title":"Bolus delivery of palonosetron through skin by tip-loaded dissolving microneedles with short-duration iontophoresis: A potential strategy to rapidly relieve emesis associated with chemotherapy","volume":"25","author":"Kang","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114517_b0805","first-page":"e131819","article-title":"Dissolving microneedles loaded with gestodene: fabrication and characterization in vitro and in vivo","volume":"22","author":"Duan","year":"2023","journal-title":"Iran J. Pharm. Res. IJPR."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124003436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124003436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:09:19Z","timestamp":1729696159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124003436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":161,"alternative-id":["S0939641124003436"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114517","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic differences between subcutaneous injection and intradermal microneedle delivery of protein therapeutics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114517"}}